Abstract

Introduction/BackgroundThe combination of carboplatin and gemcitabine is a commonly used regimen for platinum-sensitive recurrent ovarian cancer. Preclinical studies showed that ATR knockdown in ovarian cancer cell lines sensitized to a...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
“You’ve got to know when to hold ‘em, know when to fold ‘em”: ovarian cancer risk reduction in patients with endometriosis
Phillip A Romanski ... Steven R Lindheim
Fertility and sterility | VOL. 117
Phillip A Romanski, et. al.Phillip A Romanski ... Steven R Lindheim
01 May 2022
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U.A Matulonis ... B.J Monk
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 28
U.A Matulonis, et. al.U.A Matulonis ... B.J Monk
01 Mar 2017
Abstract CT091: Phase I study of intraperitoneal TRX-E-002-1 in patients with persistent or recurrent ovarian cancer, fallopian tube cancer or primary peritoneal cancer: Results of dose-escalation phase
Jermaine Coward ... Kathleen Moore
American Journal of Cancer | VOL. 79
Jermaine Coward, et. al.Jermaine Coward ... Kathleen Moore
01 Jul 2019
Abstract CT091: Phase I study of intraperitoneal TRX-E-002-1 in patients with persistent or recurrent ovarian cancer, fallopian tube cancer or primary peritoneal cancer: Results of dose-escalation phase
Jermaine Coward ... Ganessan Kichenadasse
-
Jermaine Coward, et. al.Jermaine Coward ... Ganessan Kichenadasse
01 Jul 2019
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Antibody–drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer
Antonio Gonzalez-Martin
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Antonio Gonzalez-MartinAntonio Gonzalez-Martin
10 Jul 2024
Management of recurrent and persistent malignant ovarian germ cell tumors: a narrative review
Dimitrios Nasioudis ... Farzana Dinesh Pashankar
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Dimitrios Nasioudis, et. al.Dimitrios Nasioudis ... Farzana Dinesh Pashankar
10 Jul 2024
Are we making progress in curing advanced cervical cancer—again?
Jacob Christian Lindegaard ... Richard Pötter
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Jacob Christian Lindegaard, et. al.Jacob Christian Lindegaard ... Richard Pötter
09 Jul 2024
Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome
Barin Feroz ... Verena Wieser
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Barin Feroz, et. al.Barin Feroz ... Verena Wieser
03 Jul 2024
View more papers